Nestle China JV Backs Nutritional And Rx Botanical Development
This article was originally published in The Tan Sheet
Executive Summary
Nestle Health Science and Chi-Med’s joint venture Nutrition Science Partners creates an opportunity to develop and commercialize scientifically validated botanical nutritionals and drugs, based in part on Chi-Med’s traditional Chinese medicine library of 1,200 plants and 50,000 extracts.
You may also be interested in...
Nestle Increases Health Care Investment With Galderma Control
Galderma will be the “foundation” of a new division to be called Nestle Skin Health SA, said Nestle Chairman Peter Brake-Letmathe. L’Oreal will give Nestle its 50% stake in Galderma and $4.6 billion in cash to buy back 8% of its own stock from Nestle.
Nestle Increases Health Care Investment With Galderma Control
Galderma will be the “foundation” of a new division to be called Nestle Skin Health SA, said Nestle Chairman Peter Brake-Letmathe. L’Oreal will give Nestle its 50% stake in Galderma and $4.6 billion in cash to buy back 8% of its own stock from Nestle.
Post Pumps Up Nutrition Activity With Nestle’s PowerBar, Musashi Brands
The cereal giant is bulking up its Active Nutrition Group and targeting annualized revenues of $550 million in the nutrition and weight loss sector. Post also continues diversifying its revenues with the deal.